1.  Provide an overview of the mechanism of CAR T therapy.

2.  Review both FDA-approved indications and clinical trial utilizations of CAR T therapy. 

3.  Discuss the pathophysiology and management of CAR T toxicities.

Session date: 
04/11/2019 - 8:00am to 9:00am CDT
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anand A. Patel, M.D.